Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors’ Reply

被引：0
|
作者：
Sean D. Sullivan
Kavita Patel
Jesse Green
机构：
[1] University of Washington,
[2] Roche,undefined
来源：
PharmacoEconomics | 2004年 / 22卷
关键词：
Major Public Health Concern; Simulated Population; Incremental Benefit; Fibrosis Progression; Male Cohort;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：478 / 478
相关论文
共 50 条
  • [31] Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C
    Younossi, ZM
    Singer, ME
    McHutchison, JG
    Shermock, KM
    HEPATOLOGY, 1999, 30 (05) : 1318 - 1324
  • [32] Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment
    Mariano Malaguarnera
    Giovanni Pistone
    Sergio Neri
    Marcello Romano
    Alfio Brogna
    Salvatore Musumeci
    BioDrugs, 2004, 18 : 407 - 413
  • [33] Interleukin-2 plus ribavirin versus interferon-α-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-α-2b treatment
    Malaguarnera, M
    Pistone, G
    Neri, S
    Romano, M
    Brogna, A
    Musumeci, S
    BIODRUGS, 2004, 18 (06) : 407 - 413
  • [34] Ribavirin plus either peginterferon α-2a or peginterferon α-2b for patients with chronic HCV infection?
    Eva Herrmann
    Stefan Zeuzem
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 362 - 363
  • [35] Pernicious anemia during peginterferon-α2b plus ribavirin therapy for chronic hepatitis C
    Musialik, Joanna
    Petelenz, Michal
    Blonska-Fajfrowska, Barbara
    Hartleb, Marek
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (05) : 593 - 594
  • [36] Ribavirin plus either peginterferon α-2a or peginterferon α-2b for patients with chronic HCV infection?
    Herrmann, Eva
    Zeuzem, Stefan
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (07): : 362 - 363
  • [37] COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
    Salinas Escudero, G.
    Idrovo, J.
    Rivas, R.
    Ramirez Rodriguez, J.
    Rico Alba, I. A.
    Zapata, L.
    VALUE IN HEALTH, 2009, 12 (03) : A59 - A59
  • [38] COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
    Salinas Escudero, G.
    Idrovo, J.
    Rivas, R.
    Ramirez Rodriguez, J.
    Rico Alba, I. A.
    Zapata, L.
    VALUE IN HEALTH, 2009, 12 (07) : A508 - A508
  • [39] A Comparison of Interferon alpha-2a Plus Ribavirin Combination Therapy with Peginterferon alpha-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
    Demiraslan, Hayati
    Aygen, Bilgehan
    Yildiz, Orhan
    Soyuer, Isin
    Gokahmetoglu, Selma
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (01): : 12 - 22
  • [40] Preliminary report:: Efficacy of high dose daily induction interferon α-2b plus ribavirin followed by continuing daily interferon α-2b plus ribavirin in the treatment of hepatitis C.
    King, JW
    Favrot, DR
    Markanday, A
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
12345